The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

The purpose of this study was to assess the current status of relapse prevention in schizophrenia. Fifty hospital psychiatrists in Germany were interviewed about 100 currently treated inpatients. The patients were also interviewed about their knowledge of maintenance therapy. For 75 percent of their patients, physicians fulfilled guideline recommendations when indicating the planned duration of antipsychotic maintenance therapy. However, these recommendations were not routinely communicated to the patients, and target interventions, such as psychoeducation, to guarantee continuous antipsychotic therapy were seldom used. Accordingly, patients' knowledge of the optimal duration of maintenance therapy was poor.